Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
19.4M
-
Shares change
-
+486K
-
Total reported value, excl. options
-
$85.2M
-
Value change
-
+$2.81M
-
Put/Call ratio
-
0.92
-
Number of buys
-
33
-
Number of sells
-
-21
-
Price
-
$4.40
Significant Holders of OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) as of Q2 2019
79 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - COMMON STOCK as of Q2 2019.
OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.4M shares
of 159M outstanding shares and own 12.15% of the company stock.
Largest 10 shareholders include SUMMER ROAD LLC (3.8M shares), Opaleye Management Inc. (2.95M shares), Versant Venture Management, LLC (2.22M shares), Man Group plc (2.16M shares), VANGUARD GROUP INC (1.87M shares), DELTEC ASSET MANAGEMENT LLC (1.42M shares), FMR LLC (689K shares), SV Health Investors, LLC (628K shares), STATE STREET CORP (581K shares), and GEODE CAPITAL MANAGEMENT, LLC (455K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.